A. Erdei et al., Inhibition of IgE-mediated triggering of mast cells by complement-derived peptides interacting with the Fc epsilon RI, IMMUNOL LET, 68(1), 1999, pp. 79-82
Mucosal type mast cells, in contrast to the serosal type ones, do not respo
nd to cationic agents, or to the complement-derived peptides C3a and C5a [1
]. Earlier we have found that while C3a does not activate the rat mucosal t
ype mast cells (line RBL-2H3), it strongly inhibits the IgE-mediated trigge
ring of these cells, by interfering with the Fc epsilon RI-initiated signal
ing pathway [2]. In the present study we further investigated the mechanism
of this process. It is shown, that C3a interacts with the beta-chain of th
e Fc epsilon RI complex. Binding of the complement peptide to the cells app
arently causes a decrease in the proximity of the IgE-binding Fc epsilon RI
. Investigating certain sequences of C3a we found that the inhibition is ca
used by the C-terminal sequences of the complement-peptide, ranging from po
sitions 56 to 77 and also by a shorter sequence, ranging from positions 56
to 64. The inhibitory effect of these peptides was observed both in the cas
e of RBL-2H3 cells and mouse bone marrow derived mast cells. (C) 1999 Elsev
ier Science B.V. All rights reserved.